NCT01755390View on ClinicalTrials.gov

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

August 31, 2002

Study Completion Date

October 31, 2002

Conditions

Advanced Solid Tumor

Interventions

DRUG

Cabazitaxel (XRP6258)

Pharmaceutical form: infusion solution Route of administration: Intravenous

Trial Locations (2)

Unknown

Sanofi, Paris

Sanofi, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT01755390 - A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter